Speakers
   --------

   Suman Kambhampati, Omar Aljitawi, Sid Ganguly, Stephanie L. Graff,
   Heather J. Male, Joseph McGuirk, Ruben Reyes, Casey Williams

   This activity is presented by Physicians’ Education Resource in
   conjunction with The University of Kansas Medical Center .

   Overview and Purpose
   This symposium is designed to update medical oncologists/hematologists
   and other health care professionals on potentially practice-changing
   data on the treatment of leukemia, lymphoma, and myeloma presented at
   recent international hematology/oncology meetings. Participants will
   have the opportunity to learn about these advances through
   presentations by national and regional experts, interactive case
   discussions, and question-and-answer opportunities, with the overall
   goal of integrating these advances into clinical practice as well as
   enhancing awareness of novel agents in development. Furthermore, the
   most important data will be presented in the form of a poster session,
   for which ample time will be allocated for viewing. These features
   will reinforce the key data and allow participants to see and hear the
   information in multiple formats. This program will thus provide an
   invaluable and timely opportunity for practicing
   oncologists/hematologists to increase their knowledge base and improve
   their performance in managing their patients. These meetings will also
   foster networking opportunities for community practitioners.

   New for 2011: Poster session featuring top abstracts from ASH 2010!

   Target Audience
   This educational activity is directed toward medical, surgical, and
   radiation oncologists interested in the treatment of patients with
   hematologic malignancies. Fellows, nurse practitioners, nurses,
   physician assistants, pharmacists, researchers, and other health care
   professionals interested in the treatment of hematologic malignancies
   are also invited to attend.

   Learning Objective
   At the conclusion of this symposium, you should be able to:

   Discuss and debate emerging data on and recent advances in the
   treatment of patients with hematologic malignancies and integrate key
   findings into clinical practice


   1000 E. 50th St., Kansas City, MO , 64110, United States

   Loading (May not complete on browsers without Javascript support)...

   Try again